Finance

Beta
Lists
MREO:NASDAQ
Mereo BioPharma Group plc - ADR
$0.31
-1.51%
(-0.0048) 1D
$0.30
-4.18% (-0.013)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MREO...
Open
$0.32
High
$0.32
Low
$0.30
Mkt. cap
49.99M
Avg. vol.
5.10M
Volume
3.54M
52-wk high
$3.05
52-wk low
$0.20
EPS
-$0.22
Beta
0.28
Shares outstanding
159.62M
No. of employees
39
Open
$0.32
High
$0.32
Low
$0.30
Mkt. cap
49.99M
Avg. vol.
5.10M
Volume
3.54M
52-wk high
$3.05
52-wk low
$0.20
EPS
-$0.22
Beta
0.28
Shares outstanding
159.62M
No. of employees
39
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to MREO in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for MREO in the last 3 months.
Highest
Current $0.31
$3.00 (+857.85%)
Average
$2.33 (+643.93%)
Lowest
$1.00 (+219.28%)
News stories
From sources across the web
About Mereo BioPharma Group plc - ADR
CEODenise Scots-Knight
Employees39
Founded2015
Headquarters-
SectorBiotechnology
Websitemereobiopharma.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
500.00K
-
-
-
Cost of goods sold
132.00K
-
-
-
Cost of revenue
132.00K
-
-
-
Research and development expenses
4.63M
3.82M
3.72M
4.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.49M
6.04M
4.20M
4.02M
Operating expense
10.12M
9.87M
7.62M
8.67M
Total operating expenses
10.25M
9.87M
7.62M
8.67M
Operating income
-9.75M
-9.87M
-7.62M
-8.67M
Other non operating income
-101.00K
496.00K
-6.00K
17.00K
EBT including unusual items
-14.62M
-7.02M
-7.35M
-6.72M
EBT excluding unusual items
-14.62M
-7.02M
-7.35M
-6.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-300.00K
-
Net income
-14.62M
-7.02M
-7.35M
-6.72M
Net profit margin
-2,923.20%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
589.00K
504.00K
421.00K
327.00K
Interest expense
-24.00K
-28.00K
-23.00K
-20.00K
Net interest expenses
565.00K
476.00K
398.00K
307.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.59M
-9.82M
-7.16M
-8.52M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer